Skip to main content

1 Result(s)

within Kyung Jong Kim Remove this filter Biomedicine, general Remove this filter

and

  1. Article

    Open Access

    Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial

    The standard treatment regimen for drug-sensitive tuberculosis (TB), comprising four companion drugs, requires a minimum duration of 6 months, and this lengthy treatment leads to poor adherence and increased t...

    Nakwon Kwak, Doosoo Jeon, Youngmok Park, Young Ae Kang, Kyung Jong Kim… in Trials (2022)

    Download PDF (1134 KB) View Article